These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8295710)

  • 1. Venlafaxine exhibits pre-clinical antidepressant activity in the resident-intruder social interaction paradigm.
    Mitchell PJ; Fletcher A
    Neuropharmacology; 1993 Oct; 32(10):1001-9. PubMed ID: 8295710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of the time-dependent, antidepressant-induced changes in the agonistic behaviour of resident rats by the 5-HT1A receptor antagonist, WAY-100635.
    Mitchell PJ; Redfern PH
    Behav Pharmacol; 1997 Nov; 8(6-7):585-606. PubMed ID: 9832972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is antidepressant efficacy revealed by drug-induced changes in rat behaviour exhibited during social interaction?
    Mitchell PJ; Fletcher A; Redfern PH
    Neurosci Biobehav Rev; 1991; 15(4):539-44. PubMed ID: 1792016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological effects of venlafaxine, a new antidepressant, given repeatedly, on the alpha 1-adrenergic, dopamine and serotonin systems.
    Maj J; Rogóz Z
    J Neural Transm (Vienna); 1999; 106(2):197-211. PubMed ID: 10226939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant-like effects of serotonin type-3 antagonist, ondansetron: an investigation in behaviour-based rodent models.
    Ramamoorthy R; Radhakrishnan M; Borah M
    Behav Pharmacol; 2008 Feb; 19(1):29-40. PubMed ID: 18195592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant treatment and rodent aggressive behaviour.
    Mitchell PJ
    Eur J Pharmacol; 2005 Dec; 526(1-3):147-62. PubMed ID: 16289453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological profile of venlafaxine, a new antidepressant, given acutely.
    Rogóz Z; Dziedzicka-Wasylewska M; Maj J
    Pol J Pharmacol; 1998; 50(2):107-15. PubMed ID: 9798262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open-field behavioural alterations in liver-impaired and sham-operated rats after acute exposure to the antidepressant venlafaxine.
    Kugelberg FC; Apelqvist G; Wikell C; Bengtsson F
    Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):155-61. PubMed ID: 16128909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic stress and antidepressant treatment have opposite effects on P-glycoprotein at the blood-brain barrier: an experimental PET study in rats.
    de Klerk OL; Bosker FJ; Willemsen AT; Van Waarde A; Visser AK; de Jager T; Dagyte G; den Boer JA; Dierckx RA; Meerlo P
    J Psychopharmacol; 2010 Aug; 24(8):1237-42. PubMed ID: 19942635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular adaptation to chronic antidepressant treatment: evidence for a more rapid response to the novel α₂-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, compared to the SNRI, venlafaxine.
    Serres F; Millan MJ; Sharp T
    Int J Neuropsychopharmacol; 2012 Jun; 15(5):617-29. PubMed ID: 21733241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin and Norepinephrine Reuptake Inhibitors.
    Shelton RC
    Handb Exp Pharmacol; 2019; 250():145-180. PubMed ID: 30838456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of tobacco smoke and nicotine on antidepressant and memory-improving effects of venlafaxine.
    Nowakowska E; Kus K; Florek E; Czubak A; Jodynis-Liebert J
    Hum Exp Toxicol; 2006 Apr; 25(4):199-209. PubMed ID: 16696296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring a post-traumatic stress disorder paradigm in Flinders sensitive line rats to model treatment-resistant depression II: response to antidepressant augmentation strategies.
    Brand SJ; Harvey BH
    Acta Neuropsychiatr; 2017 Aug; 29(4):207-221. PubMed ID: 27692010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of single and repeated electroconvulsive shock on the social and agonistic behaviour of resident rats.
    Mitchell PJ; Fairhall SJ; Fletcher A; Redfern PH
    Neuropharmacology; 2003 Jun; 44(7):911-25. PubMed ID: 12726823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Region-specific regulation of 5-HT1B receptors in the rat brain by chronic venlafaxine treatment.
    Vidal R; Diaz A; Pazos A; Castro E
    Psychopharmacology (Berl); 2013 Sep; 229(1):177-85. PubMed ID: 23609771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel monoamine reuptake inhibitor and potential antidepressant, S33005, induces Arc gene expression in cerebral cortex.
    Pei Q; Sprakes M; Millan MJ; Rochat C; Sharp T
    Eur J Pharmacol; 2004 Jul; 495(2-3):227-33. PubMed ID: 15838995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained administration of the antidepressant venlafaxine in rats: pharmacokinetic and pharmacodynamic findings.
    Wikell C; Hjorth S; Apelqvist G; Kullingsjö J; Lundmark J; Bergqvist PB; Bengtsson F
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Apr; 363(4):448-55. PubMed ID: 11330339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effects of the novel antidepressant venlafaxine on cognitive event-related potentials (P300), eye blink rate and mood in young healthy subjects.
    Semlitsch HV; Anderer P; Saletu B; Binder GA; Decker KA
    Int Clin Psychopharmacol; 1993; 8(3):155-66. PubMed ID: 8263313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for nuclear beta-catenin in SNRI antidepressant-induced hippocampal cell proliferation.
    Mostany R; Valdizán EM; Pazos A
    Neuropharmacology; 2008 Jul; 55(1):18-26. PubMed ID: 18511088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of venlafaxine in rational antidepressant therapy.
    Feighner JP
    J Clin Psychiatry; 1994 Sep; 55 Suppl A():62-8; discussion 69-70, 98-100. PubMed ID: 7961545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.